Pattern of MUC6 expression across 119 different tumor types: A tissue microarray study on 15 412 tumors

Mucin 6 (MUC6) is a secreted gel‐forming mucin covering the surfaces of gastrointestinal and other tissues. Published work demonstrates that MUC6 can also be expressed in several cancer types and can aid in the distinction of different tumor entities. To systematically analyze MUC6 expression in nor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pathology international 2023-07, Vol.73 (7), p.281-296
Hauptverfasser: Dwertmann Rico, Sebastian, Schliesser, Sebastian J. A., Gorbokon, Natalia, Dum, David, Menz, Anne, Büscheck, Franziska, Hinsch, Andrea, Lennartz, Maximilian, Bargen, Clara, Bawahab, Ahmed A., Luebke, Andreas M., Hube‐Magg, Claudia, Fraune, Christoph, Lebok, Patrick, Clauditz, Till S., Jacobsen, Frank, Sauter, Guido, Uhlig, Ria, Steurer, Stefan, Minner, Sarah, Marx, Andreas H., Simon, Ronald, Burandt, Eike, Hoeflmayer, Doris, Krech, Till, Bernreuther, Christian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Mucin 6 (MUC6) is a secreted gel‐forming mucin covering the surfaces of gastrointestinal and other tissues. Published work demonstrates that MUC6 can also be expressed in several cancer types and can aid in the distinction of different tumor entities. To systematically analyze MUC6 expression in normal and cancerous tissues, a tissue microarray containing 15 412 samples from 119 different tumor types and subtypes as well as 608 samples of 76 different normal tissue types was analyzed by immunohistochemistry. At least a weak MUC6 positivity was seen in 50 of 119 (42%) tumor entities. Thirty‐three tumor entities included tumors with strong positivity. MUC6 immunostaining was most frequent in mucinous carcinomas of the breast (44%), adenocarcinomas of the stomach (30%–40%) and esophagus (35%), and neuroendocrine carcinomas of the colon. Strong MUC6 staining was linked to advanced pT stage (p = 0.0464), defective mismatch repair status and right‐sided tumor location (p 
ISSN:1320-5463
1440-1827
1440-1827
DOI:10.1111/pin.13322